We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£890.00
The 2027-2032 World Outlook for NASH (Non-Alcoholic Steatohepatitis) Biomarkers
Price data last checked 91 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£890 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 7 days • 7 data points (No recent data available)
Price Distribution
Price distribution over 7 days • 1 price levels
Price Analysis
Most common price: £890 (7 days, 100.0%)
Price range: £890 - £890
Price levels: 1 different prices over 7 days
Product Specifications
- Format
- paperback
- ASIN
- B0GNSQV2DT
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 05 January 2026
- Listed Since
- 17 February 2026
Similar Products You Might Like
The 2021-2026 World Outlook for Liver Disease Treatments
The 2023-2028 Outlook for Liver Health Supplements in India
The 2023-2028 Outlook for Liver Health Supplements in the United States
The 2023-2028 Outlook for Liver Cirrhosis Drugs in India
Non-Alcoholic Steatohepatitis: Methods and Protocols: 2455 (Methods in Molecular Biology, 2455)
Humana
Humana Non-Alcoholic Steatohepatitis Methods and Protocols 2455
Humana
NAFLD and NASH: Biomarkers in Detection, Diagnosis and Monitoring
Springer
NAFLD and NASH: Biomarkers in Detection, Diagnosis and Monitoring
Springer
The 2025-2030 World Outlook for Liver Disease Treatments
The 2023-2028 Outlook for Liver Health Supplements in China
The 2023-2028 Outlook for Liver Health Supplements in Japan
The 2023-2028 Outlook for Hepatitis B Diagnostic Tests in India
Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis
IntechOpen
The 2023-2028 Outlook for Liver Cirrhosis Drugs in China
The 2023-2028 Outlook for Liver Health Supplements for US Zip Codes
The 2023-2028 Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments in the United States
The 2025-2030 World Outlook for Liver Cirrhosis Drugs
The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in Greater China
Nonalcoholic Steatohepatitis (NASH): Symptoms, Risk Factors and Treatments: Symptoms, Risk Factors and Treatments (Hepatology Research and Clinical Developments)
The 2023-2028 Outlook for Liver Cirrhosis Drugs for US Zip Codes
The 2025-2030 World Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments
Need-to-Know NAFLD: The Complete Guide to Nonalcoholic Fatty Liver Disease
CRC Press
Metabolic Steatotic Liver Disease: Current Knowledge, Therapeutic Treatments, and Future Directions
Academic Press
